These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 38474580)
1. Recently Reported Biological Activities and Action Targets of Pt(II)- and Cu(II)-Based Complexes. Maciel-Flores CE; Lozano-Alvarez JA; Bivián-Castro EY Molecules; 2024 Feb; 29(5):. PubMed ID: 38474580 [TBL] [Abstract][Full Text] [Related]
2. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity. Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175 [TBL] [Abstract][Full Text] [Related]
3. Novel metals and metal complexes as platforms for cancer therapy. Frezza M; Hindo S; Chen D; Davenport A; Schmitt S; Tomco D; Dou QP Curr Pharm Des; 2010 Jun; 16(16):1813-25. PubMed ID: 20337575 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and antimicrobial activities of Cu(II), Co(II), Pt(II) and Zn(II) Complexes with N,O-chelating heterocyclic carboxylates. Buczkowska M; Bodtke A; Lindequist U; Gdaniec M; Bednarski PJ Arch Pharm (Weinheim); 2011 Sep; 344(9):605-16. PubMed ID: 21695713 [TBL] [Abstract][Full Text] [Related]
5. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties. Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390 [TBL] [Abstract][Full Text] [Related]
6. An Evaluation of the Antioxidant and Anticancer Properties of Complex Compounds of Copper (II), Platinum (II), Palladium (II) and Ruthenium (III) for Use in Cancer Therapy. Katarzyna M; Anna S; Zielinska-Blizniewska H; Ireneusz M Mini Rev Med Chem; 2018; 18(16):1373-1381. PubMed ID: 29692246 [TBL] [Abstract][Full Text] [Related]
7. Organoselenium transition metal complexes as promising candidates in medicine area. Kostić M; Marjanović J; Divac V J Biol Inorg Chem; 2024 Sep; 29(6):555-571. PubMed ID: 39123093 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin. Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754 [TBL] [Abstract][Full Text] [Related]
9. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin. Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700 [TBL] [Abstract][Full Text] [Related]
10. Anticancer Metallocenes and Metal Complexes of Transition Elements from Groups 4 to 7. Kostova I Molecules; 2024 Feb; 29(4):. PubMed ID: 38398576 [TBL] [Abstract][Full Text] [Related]
11. Metallopharmaceuticals in Therapy - A New Horizon for Scientific Research. Chylewska A; Biedulska M; Sumczynski P; Makowski M Curr Med Chem; 2018; 25(15):1729-1791. PubMed ID: 29210637 [TBL] [Abstract][Full Text] [Related]
12. Elaborated studies for the ligitional behavior of thiouracil derivative towards Ni(II), Pd(II), Pt(IV), Cu(II) and UO2 ² ions. Abou-Melha KS Spectrochim Acta A Mol Biomol Spectrosc; 2012 Nov; 97():6-16. PubMed ID: 22743608 [TBL] [Abstract][Full Text] [Related]
13. Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes. Gałczyńska K; Drulis-Kawa Z; Arabski M Molecules; 2020 Jul; 25(15):. PubMed ID: 32751963 [TBL] [Abstract][Full Text] [Related]
15. Metal Ion Complexes with Pyrazoles, Aziridines and Diaziridines - Synthesis and Biological Activity. Malinowska K; Lorenz IP; Sadowska B; Mucha P Curr Med Chem; 2019; 26(4):648-663. PubMed ID: 29473492 [TBL] [Abstract][Full Text] [Related]
16. Metal Complexes as Promising Agents for Biomedical Applications. Loginova NV; Harbatsevich HI; Osipovich NP; Ksendzova GA; Koval'chuk TV; Polozov GI Curr Med Chem; 2020; 27(31):5213-5249. PubMed ID: 31038054 [TBL] [Abstract][Full Text] [Related]
17. A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies. Adhikari S; Nath P; Das A; Datta A; Baildya N; Duttaroy AK; Pathak S Biomed Pharmacother; 2024 Feb; 171():116211. PubMed ID: 38290253 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II). Yadav AA; Patel D; Wu X; Hasinoff BB J Inorg Biochem; 2013 Sep; 126():1-6. PubMed ID: 23707906 [TBL] [Abstract][Full Text] [Related]
19. Physico-Chemical Study of Mn(II), Co(II), Cu(II), Cr(III), and Pd(II) Complexes with Schiff-Base and Aminopyrimidyl Derivatives and Anti-Cancer, Antioxidant, Antimicrobial Applications. Al-Fakeh MS; Alsikhan MA; Alnawmasi JS Molecules; 2023 Mar; 28(6):. PubMed ID: 36985526 [TBL] [Abstract][Full Text] [Related]
20. Group-10 metal complexes of biological molecules and related ligands: structural and functional properties. Shimazaki Y; Yamauchi O Chem Biodivers; 2012 Sep; 9(9):1635-58. PubMed ID: 22976959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]